We report the first complete nucleotide sequence of the picornavirus coxsackievirus B5 (CB5), strain 1954/ UK/85, an isolate from a case of hand-foot-and-mouth disease. We have compared the sequence with those of other coxsackie B viruses, coxsackievirus A9, poliovirus and swine vesicular disease virus (SVDV). The genes encoding the three major capsid proteins are most closely related to those of SVDV but the 5' and 3' noncoding regions and the P3 gene are more similar to the corresponding regions in the other coxsackie B viruses than to those of SVDV. These observations are considered in the light of the antigenic and biochemical relationships between SVDV and CB5.
Introduction
Coxsackieviruses are human enteroviruses within the family Picornaviridae. Their division into two groups (A and B) is based largely on their pathogenicity and replication in newborn mice. Both groups have been associated with a wide variety of neurological, cardiovascular, gastroenteric, ophthalmic and exanthematic diseases. The main natural host of coxsackieviruses is man but several studies have established that swine vesicular disease virus (SVDV) and coxsackievirus B5 (CB5) are antigenically closely related. SVDV can be neutralized by CB5 antisera and vice versa (Graves, 1973; Brown et al., 1973) but they are distinguishable by immunodiffusion tests and in some reciprocal crossneutralization tests (Brown et at., 1973) . RNA-RNA hybridization experiments showed considerable levels of similarity between SVDV and CB5 (Brown & Wild, 1974; Brown et al., 1976b; Harris et al., 1977) .
It has been suggested that CB5 gave rise to the agent of SVD (Graves, 1973) , but the reverse is also theoretically possible. However, isolation of CB5 predates the isolation of SVDV by 14 years and the geographical distribution of SVDV infection of pigs always correlates with clinical SVD or prior infection. In addition to pigs, SVDV has been reported to infect man (Brown et al., 1976a) which can result in a coxsackie-like neurological illness. CB5 can also infect pigs, usually without signs of disease; however lesions in the central nervous system have been observed microscopically in
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infected animals, and the lesions are similar to those seen in pigs infected with SVDV (Garland & Mann, 1974; Monlux et al., 1975; Lai et al., 1980) . Whatever the precise origins of CB5 and SVDV, it is clear they are related and they can cause similar disease symptoms in humans and pigs.
Comparison of the available nucleotide sequences indicates there are currently four subgroupings based on the similarities of nucleotide sequence within enteroviruses, such that poliovirus types 1, 2 and 3 (PV1, -2 and -3), coxsackievirus A21 (CA21) and CA24 form one group; CB1, CB3, CB4, CA9 and SVDV form another; enterovirus 70 and bovine enterovirus 1 are each distinct (our unpublished comparisons) .
In this paper we report the first complete nucleotide sequence of CB5 virus. The virus strain chosen for analysis, CB5/1954/UK/85, was isolated from an individual with hand-foot-and-mouth disease. We compare the nucleotide sequence of this virus with those of other enteroviruses and, in particular, with SVDV.
Methods
Virus and cells. The strain of CB5, 1954/UK/85, was obtained from the vesicular fluid within skin lesions of a patient with hand-foot-andmouth disease, passaged on baboon kidney cells four times and kindly given to us by J. Mills (Public Health Laboratory Service, Peterborough, U.K.). The virus was grown in IB-RS-2 cells, and purified by 15 to 45% sucrose density gradient centrifugation, as described previously (Seechurn et al., 1990) .
RNA isolation, cDNA synthesis and cloning. The CB5 genomic RNA was isolated from purified virus by the acid guanidinium thiocyanate method (Chomczynski & Sacchi, 1987) , and used in cDNA syntheses. The primers used for synthesizing first-strand cDNA were olig°(dT)l~ 18 (Sigma) and two synthetic oligonucleotides: svd-18a TAATCGGTTGTACATC TTCACCGTGGC GGTGCCTCAAACAAAAGGTGTCGCAGTAT TATGGAATACCCATGGCTGAGC GGCAGAATAATAACTGGCTTAAAAAGTTCACTGAAATGACCA 4080
ACCCTG TTATGCC TATGAAAGACATACA~GAGTCAATCAGAT~ACCAAGGACCCAAAAAATACCCAAC~CCATGTGCGTTCATTGTGCTTATTGGCTTGGCACAATGGAG/%ACACGAAT 7200
ATGAGGAGTTTATCAAAAhJU~TCAG~GCGTCCCAGTTGGGCGTTGCTTGAC~TTGCCTGCGTTTTC~CTTTACGCAG~AAATGGTTGGACTCCT~TTAGATTAGAGGC~TTTC~TT 7320 (CGCTGACCCGCAAAACAT), complementary to the sequence of nucleotides 2087 to 2104 of the SVDV genome (Seechurn et al., 1990) , and b5-1 (ACCGCGGTACCAGAGT), complementary to the sequence of nucleotides 52 to 68 of the CB5 genome. First-strand cDNA synthesis was performed on 2 gg purified virus RNA using Moloney murine leukaemia virus reverse transcriptase (Bethesda Research Laboratories) by incubating at 37 °C for 1 h, and second-strand cDNA synthesis was performed using two strategies. The first was that described by Watson & Jackson (1985) ; cDNA was fractionated in Sephacryl S-500 and cloned into the plasmid vector Bluescript SK + (Stratagene). For the extreme 5' end, first-strand cDNA was made with oligonucleotide b5-1 and copied by using Thermus aquaticus DNA polymerase (Boehringer-Mannheim) and a synthetic oligonucleotide, b5-3 (TTAAAACAGCCTGTGGGTTG), complementary to the sequence of nucleotides 1 to 20 of other coxsackievirus genomes. The product was then phosphorylated with T4 polynncleotide kinase in the presence of 1 mM-ATP, digested with Nhel, and cloned into pBCV-S1 which had been restricted with HindIII, end-filled using Klenow polymerase and then restricted with NheI. Subetoning and determination of nucleotide sequence. Nucleotide sequences were determined by the chain termination method (Sanger et al., 1977) using Sequenase (United States Biochemical). Snbclones were generated either by sonication and subcloning into M 13mp 18 or -mp 19 (Yanisch-Perron et al., 1985) or by deletion using exonuclease III and nuclease S1 (Henikoff, 1984) . Direct RNA sequencing was performed on the virus genome RNA using b5-1 and avian myeloblastosis virus reverse transcriptase (Promega) as described by McCanley & Penn (1990) .
Computer analysis. Sequences were analysed using version 7.0 of the GCG package (Devereux et al., 1984) and the DB system (Staden, 1987) . A personal computer program was used to generate Fig. 2 . Alignment of 1B, 1C and 1D sequences was done using MULTALIN (Corpet, 1988) .
Results and Discussion

Nucleotide sequence of CB5/1954/UK/85
The complete nucleotide sequence of a CB5 strain was assembled from the sequences of three individual cDNA clones. The clones extended from bases 1 to 2117 (pBCV-NTR1), 41 to 2117 (pBCV-S1), and 1811 to the 3' poly(A) tail (pBCV-67). These cDNA clones were obtained by cloning cDNA prepared following reverse transcription using the specific primer svd-18a (pBCV-S1) or oligo(dT) (pBCV-67), or by cloning a short fragment corresponding to the 5' terminus (clone pBCV-NTR1) into pBCV-S1 which was synthesized using primers based on the terminal sequence determined by direct RNA sequencing. Each ,base of the cDNA sequence was covered at least twice, and the average coverage was 5. The genome is 7402 nucleotides in length [excluding the poly(A) tail] and features a 5' non-coding region of 743 nucleotides and a 3' non-coding region of 101 nucleotides prior to the poly(A) sequence.
The nucleotide sequence together with the derived amino acid sequence and the deduced processing sites in the polyprotein precursor are presented in Fig. 1 . The assignment of cleavage sites within this polyprotein precursor was made to maximize homologies with other picornaviruses as discussed before (Seechurn et al., 1990) .
5" Non-coding region
The 5' non-coding region of the picornavirus genome is believed to form secondary and higher order structures and contains an internal ribosome entry site and signals for the control of virus replication and assembly. Biochemical and genetic data have been used to support a model of the 5' non-coding region of poliovirus (Skinner et al., 1989; Pilipenko et al., 1989) . The 5' noncoding sequences of CB1 (Iizuka et al., 1987) , CB3 and CB4 (Skinner et al., 1989) , CA9 (Chang et al., 1989) and SVDV (Inoue et al., 1989; Seechurn et al., 1990) are also generally consistent with this proposed structure. The 5' non-coding region of CB5 shows between 55 and 75 % nucleotide sequence identity to PV1 and a somewhat higher (65 to 95 %) identity to other coxsackieviruses and SVDV. The predicted secondary structure of the 5' non-coding region of CB5 is also fully consistent with the proposed secondary structure within the enteroviruses, save the loss of a stem structure of 6 bp at positions 188 to 194 complementary to positions 222 to 227 (PV3 numbering). This stem is also absent from CB 1 (Iizuka et al., 1987) , CB3 and CB4 (Skinner et al., 1989) as well as from SVDV (Seechurn et al., 1990) and CA9 (Chang et al., 1989) .
Capsid polypeptides
The three-dimensional structures have been determined for several picornaviruses including PV1 (Hogle et aI., 1985) and PV3 (Filman et al., 1989) . As a result of the considerable sequence homology between these viruses, and SVDV and coxsackie B viruses, the variable sites within CB5 and SVDV can be mapped to equivalent specific locations in the virus particle. We show in Table  1 a comparison of the amino acid sequence of CB5 polypeptides with those of other closely related enteroviruses. We have also made alignments of the amino acid Table 1 . Percentage amino acid sequence identity of predicted coxsackievirus B5 with those of other selected enteroviruses sequences of the outer capsid proteins 1B (VP2), 1C (VP3) and 1D (VP1) of SVDV, PV1, the coxsackie B viruses and CA9 (data not shown), comparable to those described previously (Seechurn et al., 1990) . From this alignment we see that CB5 can be aligned collinearly with SVDV but insertions and deletions are needed to align 1B, 1C and 1D with the other coxsackieviruses, CB1 (seven deletions/insertions of amino acids), CB3 (four deletions/insertions), CB4 (one insertion) and CA9 (two single amino acid insertions and an insertion at the C terminus of 1D). It is clear that the CB5 capsid is most closely related to that of SVDV. There are 42 amino acid substitutions between CB5 and each of the SVDV strains which have been sequenced. The amino acid sequence variation seen between CB5 and SVDV strains is greatest in the puff in 1B which is the equivalent of the capsid structure forming part of antigenic site 2 of PV1. Other changes elsewhere include the equivalents of poliovirus antigenic sites 1 and 3B, and the loop connecting/?-sheet D with/?-sheet E1 in 1D.
On the basis of these observations which relate only to proteins, we conclude that in the outer capsid region, SVDV and CB5 can be considered antigenic variants of a single serotype and this is consistent with both the cross-neutralization data, and the proposal that the immunological cross-reactivity of SVDV and CB5 particles derives from their similar overall primary structure.
Non-structural polypeptides
The non-structural polypeptides (P2 and P3 precursors) of enteroviruses exhibit a relatively high degree of conservation of amino acid sequence. The non-structural polypeptides are involved in replication and processing, and several structural motifs can be adduced from their amino acid sequence. These structural motifs, i.e. the protease motif and helicase/NTP-bonding motif (as I  I  I  I  I  I  I  I  l  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I discussed before ; Seechurn et al., 1990) , are preserved in CB5. Table 1 shows amino acid sequence homologies between CB5 and other coxsackie B viruses for which complete genome sequence data are available and two isolates of SVDV and a partial genomic sequence of echovirus 11. We conclude from this analysis that in contrast to the outer capsid polypeptides, the nonstructural polypeptides of CB5 are more closely related to those of other coxsackie B viruses than to those of the SVDV strains.
Overall nucleotide sequence homology
Inspection of the amino acid sequence homologies between the coxsackie B viruses prompted us to examine the homologies of the nucleotide sequences of these viruses in more detail. For this we developed a computer program which performs a stepwise comparison of sequences between two genomes and graphically charts the relative homology between the two. In Fig. 2 , we show the results obtained from comparing sequences in a moving window of a 300 nucleotide block with a step of 12 nucleotides. Thus, we show in Fig. 2(a) the nucleotide sequence of CB5 compared with PV1, CB1 and SVDV, and in Fig. 2 (b) we show SVDV compared to PV1, CB5 and CB1. These results typify those also obtained from using CB3, CB4 or CA9 in comparison with CB5 or SVDV and PV1 (not shown).
The results of the nucleotide sequence comparisons confirm that (of those under consideration) CB5 is most closely related to SVDV in the region of the genome that encodes virus outer capsid polypeptides. However it is clear that in other regions the relative homology between the viruses is not maintained. In the 5' non-coding region, CB5 is most closely homologous to any of the coxsackie B viruses rather than to SVDV, and in the region of the genome following the capsid proteins, encoding P2, 3A and 3B, all the coxsackie B viruses and SVDV are similarly related to each other. The genomic sequence encoding 3C and 3D of CB5 is, however, homologous to SVDV to a lesser degree than to any of the other CB viruses. Comparisons of SVDV with CB 1, CB5 and PV1 (Fig. 2b) similarly shows that in the 5' noncoding region SVDV is no more closely related to CB5 than it is to CB 1, and a similar relationship is seen in the region of the genome encoding 3C and 3D; SVDV is equally related to both CB5 and CB1. However, in the capsid region SVDV is more akin to CB5 than it is to any of the other viruses as expected.
There are a number of partial genome sequences available for enteroviruses and we have compared these to SVDV and CB5. A striking result emerged from a comparison of SVDV with the sequence encoding 615 nucleotides within 3BC of echovirus 9 (Barty strain) (Werner et al., 1986) : SVDV is more closely related to echovirus 9 in the region of the genome encoding 3BC than to any of the coxsackieviruses (Fig. 2c) . We are currently examining to what degree the observed homology in 3BC extends to other regions of the genome.
From these comparisons, it appears that SVDV is not particularly any more closely related to CB5 virus (or at least to CB5/1954/UK/85) than it is to other coxsackie B viruses except in the region of the genome that encodes the capsid polypeptides. This suggests that SVDV and CB5 could have arisen in any of three ways: (i) they arose from a common ancestral virus retaining close homology in the capsid coding region while accumulating divergence elsewhere; (ii) they arose from two ancestral coxsackie-like viruses by convergent evolution of their capsid genes; (iii) they arose by recombination.
It is established that enteroviruses can regularly undergo genetic recombination and intertypic poliovirius recombinants can be recovered in nature (Kew & Nottay, 1984; Lipskaya et aI., 1991) . It has also been reported that the 5' non-coding regions of coxsackie B virus show a closer relationship to each other when classified by year of isolation than when classified by virus (Pallansch & Freeman, 1987) , thus further supporting the notion that RNA recombination is common in picornaviruses. Based on these precedents it is possible that SVDV and/or CB5/1954/UK/85 are mosaic viruses in which individual regions of the genome have come together through genetic recombination to form new viable viruses.
Since RNA virus genomes are highly mutable, sequence differences quickly accumulate. An alternative depiction of the relationships within the P3-coding region between viruses that we have discussed here is that the result of rapid accumulation of mutation could result in 'sampling errors' from a population of 10 to 20% sequence variation. The accumulation of mutations may also be increased due to adaptation to replication in a new host. These could be selected, for example, through interactions of virus with host factors or by selection of viruses with more effective codon choice. We have examined codon usage and see no striking change in usage between SVDV and CB5. Alternatively, neutral mutations may have become fixed more rapidly in SVDV through virus replication (from time to time) in a small population.
The relationship between CB5 and SVDV is reminiscent in principle of the sequence variation seen between a type 3 poliovirus isolated during an outbreak of poliomyelitis in Finland and the prototype type 3 (Leon) and the prototype type 1 (Mahoney) strains (Hughes et al., 1986) . Here the 5' non-coding region of the Finnish virus was more homologous to PV1 than it was to PV3; but in the non-structural polypeptides the virus from Finland was equally closely related in amino acid sequence to PV1, PV2 and PV3. To compare the relative homology seen in these polioviruses with the homology between CB5 and SVDV we show in Fig. 2(d) a graph of the homology of PV1 and PV3. Within the P3 coding region of the genome a closer relationship is evident in this graph between PV3 (Leon) and PV1 (Mahoney) than can be seen between PV3 (Leon) and PV3 (Finland). Hughes et al. (1986) deduce that PV3 (Finland) and PV3 (Leon) were descended from independent lineages of PV3 rather than having arisen by intertypic recombination. The degrees of sequence variation within enterovirus serotypes (CB5 and SVDV, and PV3 Leon and PV3 Finland) are both very similar (from Fig. 2 a, b and d) .
We are unable to draw any firm conclusion about the origin of CB5 and SVDV but we are currently investigating the possibilities raised above by examining a wide range of CB5 and SVDV strains and our preliminary data indicate that CB5/1954/UK/85 is not an atypical strain of CB5.
The relationship between SVD V and CB5
Although results from antigenic and biochemical analysis have shown close similarities between SVDV and CB5 strains, differences can be detected. In detailed studies on RNA hybridization and T1 oligonucleotide mapping, Harris et al. (1977) showed detectable genetic variation within SVDV strains and suggested that, for those examined, SVDV strains were members of a closely related group, but that the two CB5 strains they examined were less similar to each other. Moreover, the analysis carried out by Harris et al. (1977) failed to detect any long T1 oligonucleotides common to both SVDV and CB5. These observations are consistent with our sequence data since two SVDV strains (Seechurn et al., 1990; Inoue et al., 1989) differ by only 98 base substitutions. The failure to observe long oligonucleotides conserved between SVDV and CB5 is consistent with the degree of similarity over the complete genome of the CB5 strain which we report here.
Conclusions
We have shown that the CB5/1954/UK/85 has regions of similarity to SVDV in the capsid region which is likely to explain the cross-neutralization of SVDV and CB5 by their respective antisera. However other regions of the CB5 genome are less closely related to SVDV than they are to other coxsackieviruses. We submit that the evolution of SVDV is likely to be more complex than a simple adaptation of CB5 to replication in pigs. It is possible that genetic recombination has led to the emergence of SVDV or at least some strains of CB5.
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